跳至主要内容
临床试验/NCT06695247
NCT06695247招募中不适用

Mobility Outcomes in Post-Pulmonary Embolic Disease (MOPED): A Pilot Feasibility Prospective Randomized Trial

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年7月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
Mayo Clinic
入组人数
100
试验地点
1
主要终点
Change in physical capacity from baseline

研究概览

简要总结

The purpose of this study is to develop a unique structure and delivery of home-based exercise through multidisciplinary expertise of cardiovascular medicine specialists and cardiac physiologists using an Interactive Care Plan.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Acute intermediate-risk PE, defined as:
  • •Intraluminal filling defect in segmental or larger vessels on computed tomography pulmonary angiography or high-probability ventilation/perfusion scan AND
  • •Evidence of right ventricular enlargement by computed tomography (RV to LV ratio >1) or echocardiography; and/or right ventricular dysfunction by transthoracic echocardiography. These imaging characteristics must be in the setting of acute PE rather than explained by a prior chronic condition.
  • •Acute high-risk PE, defined as:
  • •Intraluminal filling defect in segmental or larger vessels on computed tomography pulmonary angiography or high-probability ventilation/perfusion scan AND
  • •Evidence of right ventricular enlargement by computed tomography (RV to LV ratio >1) or echocardiography; and/or right ventricular dysfunction by transthoracic echocardiography. These imaging characteristics must be in the setting of acute PE rather than explained by a prior chronic condition; AND
  • •Hypotension (systolic blood pressure < 90 mm Hg sustained for more than 15 minutes; or requiring vasopressors) or cardiogenic shock due to acute pulmonary embolism.

排除标准

  • •Inability to ambulate independently, which is necessary to perform 6MWD (may be self-reported or as deemed by physical therapy during inpatient evaluation).
  • •If patient requires supplemental oxygen during ambulation, this does not exclude patient from participation and will be noted during eCRF.
  • •Prior history of pulmonary embolism
  • •History of CTEPH or pulmonary arterial hypertension
  • •Unable to read a questionnaire in English
  • •Unable to return for baseline, 3- or 6-month follow-up visit
  • •Pregnancy-associated pulmonary embolism
  • •Life expectancy <1 year based on comorbidities
  • •Unable/unwilling to provide informed written consent

研究组 & 干预措施

Home-Based Exercise Training

Experimental

干预措施: Exercise Training (Other)

Standard therapy (Standard of Care)

No Intervention

结局指标

主要结局

Change in physical capacity from baseline

时间窗: Baseline, 3 Months, 6 Months

Physical capacity will be determined by 6-minute walk distance (6MWD)

次要结局

  • Change in Pulmonary Embolism-specific quality of life (PEmb-QOL) outcome measures from baseline(Baseline, 3 Months, 6 Months)
  • Change in general Short Form 36 (SF-36) quality of life outcome measures from baseline(Baseline, 3 Months, 6 Months)
  • Number of Steps(Baseline, 3 Months, 6 Months)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Stan Henkin

Associate Professor of Medicine

Mayo Clinic

研究点 (1)

Loading locations...

相似试验

A Study of Mobility Outcomes in Post-Pulmonary... | 临床试验